Johnson, S. C., Williams, D. C., Brinton, D., Chew, M., Simpson, A., & Andrews, A. L. (2021). A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment. Hosp Pediatr.

Johnson, Scarlett Carmen, Daniel Clay Williams, Daniel Brinton, Marshall Chew, Annie Simpson, και Annie Lintzenich Andrews. "A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment." Hosp Pediatr 2021.

Johnson, Scarlett Carmen, et al. "A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment." Hosp Pediatr 2021.